Febrile neutropenia (FN) is a condition characterized by a decrease in the level of neutrophils in the blood against the background of an increase in temperature, which may indicate an infectious process. Neutrophils are key cells of the immune system responsible for protecting the body from infections, especially bacterial ones. Patients with febrile neutropenia have a high susceptibility to infections that can progress rapidly and be life-threatening. This condition often occurs in patients undergoing chemotherapy, with various hematological diseases and may require emergency medical care.
History of the disease and interesting historical facts
Febrile neutropenia was first described in the 1960s in the context of the treatment of lymphomas and solid tumors in patients receiving chemotherapy. Since then, FN has been recognized as one of the most serious complications of cancer treatment. Studies in the following decades have revealed that FN occurs in 20-40% patients undergoing chemotherapy, depending on the type and intensity of treatment. Increasing understanding of the mechanisms leading to this condition has facilitated the development of more effective diagnostic and therapeutic methods.
Epidemiology
Febrile neutropenia is a common problem in oncology. According to various studies, FN develops in 30-50% patients undergoing modern chemotherapy regimens. The peak incidence is observed on the 7-10th day after the chemotherapy course. It is also important that in recent years there has been an increase in the number of FN cases in elderly patients, which is associated with the characteristics of the aging immune system and comorbid pathology.
Genetic predisposition to this disease
Genetic predisposition to febrile neutropenia may be associated with mutations in various genes responsible for the functioning of blood cells and the immune system. One such gene is the CYBA gene, which codes for a protein involved in the formation of reactive oxygen species needed to destroy pathogens. Mutations in this gene can lead to decreased functionality of neutrophils and an increased likelihood of infections. In addition, genetic abnormalities associated with other components of the immune system, such as cytokines and their receptors, can also increase the risk of febrile neutropenia.
Risk factors for the development of this disease
Risk factors that contribute to the development of febrile neutropenia can be divided into several categories:
- Chemotherapy: Most cases of FN are registered in patients receiving cytostatic drugs.
- Comorbid conditions: diseases such as diabetes, renal failure and liver cirrhosis increase the risk of developing neutropenia.
- Age: Older adults have a higher risk of developing FN due to age-related changes in the immune system.
- Infectious diseases: The presence of an active infection, especially viral and fungal, may precede the development of febrile neutropenia.
- Genetic factors: A predisposition to low levels of neutrophils in the blood may be inherited.
Diagnosis of this disease
Diagnosis of febrile neutropenia involves several key steps.
- Main symptoms: temperature above 38°C combined with a decrease in the level of neutrophils (less than 1500/μl) is the main sign.
- Laboratory tests: complete blood count with neutrophil count and cultures for infections.
- Radiologic tests: May include chest x-ray or CT scan to look for foci of infection.
- Other diagnostic tests: A bone marrow biopsy may be required to rule out malignant processes.
- Differential diagnosis: It is important to exclude other causes of fever, such as sepsis, pulmonary infections, etc.
Treatment
Treatment of febrile neutropenia is a complex and multi-level process that requires an individual approach.
- General treatment: if FN is detected, hospitalization in a specialized department is necessary.
- Pharmacological treatment: Broad-spectrum antibiotics such as cephalosporins and carbapenems are most commonly used.
- Surgical treatment: may be required if abscesses or other surgical complications are detected.
- Other treatments: Colony-forming factor (CFF) stimulants may be used to increase the level of neutrophils in the blood.
List of medications used to treat this disease
The main drugs used in the treatment of febrile neutropenia include:
- cefepime
- Meropenem
- Cyprofloxacin
- Granulocyte colony-stimulating factor (filgrastim)
- Tazobactam/piperacillin
Disease monitoring
Monitoring of a patient with febrile neutropenia should include regular monitoring of temperature and neutrophil count.
- Control stages: blood tests are performed every week or more often depending on the dynamics of the condition.
- Prognosis: With early diagnosis and adequate treatment, the prognosis for life can be favorable, however, late intervention can lead to complications.
- Complications: These include sepsis, severe infections, and persistent deterioration in organ function.
Age-related features of the disease
Febrile neutropenia has different course characteristics depending on the patient's age. In children, especially newborns, FN may be more acute and require intensive treatment. Elderly patients develop more frequent and severe infections, as well as a high risk of complications associated with comorbid pathology.
Questions and Answers
- What is febrile neutropenia? Febrile neutropenia is a condition characterized by a decrease in neutrophil levels and an increase in temperature that often precedes infectious diseases.
- What are the main causes of FN? FN often occurs in patients receiving chemotherapy, but can also be caused by infections and immunodeficiency states.
- How is this condition diagnosed? Diagnosis includes blood tests for neutrophil levels and temperature, as well as additional studies to identify infectious sources.
- What are the prospects for treating FN? With early diagnosis and adequate treatment, most patients with FN have a favorable prognosis.
- What to do if you have a high temperature after chemotherapy? It is necessary to immediately consult a doctor for diagnosis and, if necessary, start treatment.
Advice from Dr. Oleg Korzhikov:
When caring for patients with febrile neutropenia, it is important to follow several key guidelines:
— **Monitor your temperature**: Monitor your temperature daily and report any increase to your doctor immediately.
— **Practice good hygiene**: Wash your hands thoroughly, avoid large crowds, and minimize contact with infectious agents.
— **Pay attention to symptoms of infection**: Any changes in general condition, such as aches, coughing, or unusual redness of the skin, should be promptly assessed.
Febrile neutropenia requires careful attention and prompt response from both the medical staff and the patient. Understanding the mechanism of this condition and active cooperation with physicians can significantly reduce the risk of serious complications.
